PER 0.00% 10.5¢ percheron therapeutics limited

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,425 Posts.
    lightbulb Created with Sketch. 1439
    Using the Plasma from DMD trial Anp has the results to go forward with proof of concept by doing animal studies to be trialled ...2nd half 2021..
    More announcements to follow $$$$$

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.